A client with cystitis receives a prescription for phenazopyridine. Which information should the nurse explain to the client about its therapeutic effect?

Choice A reason:

Decreased episodes of incontinence are not a relevant outcome of administering zolpidem. Zolpidem is a sedative-hypnotic medication primarily used to treat insomnia by enhancing the activity of GABA, an inhibitory neurotransmitter. It does not affect urinary function or bladder control. Incontinence may be caused by other factors such as aging, prostate problems, or urinary tract infections, but it is not influenced by zolpidem.

Choice B reason:

Improved ability to concentrate is not a pertinent outcome of administering zolpidem. This medication does not enhance cognitive function or attention span. In fact, zolpidem may impair memory and cause daytime drowsiness or confusion in some patients. Its primary function is to induce sleep, not to improve concentration.

Choice C reason:

Exhibiting fewer emotional outbursts is not a significant outcome of administering zolpidem. This medication does not affect mood or behavior. In some cases, zolpidem may cause paradoxical reactions such as agitation, aggression, or hallucinations, especially in older adults. Therefore, it is not used to manage emotional outbursts.

Choice D reason:

Sleeps soundly through the night is the desired outcome of administering zolpidem. This medication is specifically designed to treat sleep problems, particularly difficulty falling asleep or staying asleep. By enhancing the activity of GABA, zolpidem helps induce and maintain sleep, which is the primary goal when prescribing this medication to patients with insomnia.

Choice A Reason:

Providing a PRN dose of antacid along with the scheduled medications is not the best option. Antacids can interfere with the absorption of other medications, including sucralfate and pantoprazole. Sucralfate works by forming a protective barrier on the ulcer site, and pantoprazole is a proton pump inhibitor that reduces stomach acid production. Adding an antacid could alter the effectiveness of these medications.

Choice B Reason:

Instructing the client to take the dose of sucralfate PO while eating breakfast is incorrect. Sucralfate should be taken on an empty stomach, typically one hour before meals, to ensure it can effectively coat the ulcer site and provide protection. Taking it with food can reduce its efficacy.

Choice C Reason:

Holding the dose of IV pantoprazole until the client has finished eating breakfast is not advisable. Pantoprazole is most effective when taken before meals, as it helps to reduce stomach acid production in anticipation of food intake. Delaying the dose could result in less effective acid suppression and increased discomfort for the patient.

Choice D Reason:

Administering both of the medications before breakfast as scheduled is the correct action. Sucralfate should be taken on an empty stomach to form a protective barrier on the ulcer site, and pantoprazole should be administered before meals to reduce stomach acid production. This timing ensures both medications work optimally to manage the patient’s peptic ulcer disease and alleviate symptoms like heartburn.